July 14, 2024

Cell Expansion Market is driven by Rapid Advancement in Tissue Engineering and Regenerative Medicine

Cell Expansion technology allows the growth of biological cells in all three dimensions to form a three-dimensional cellular construct that imitates natural tissues. Cell Expansions are used to grow various cell lines from different organisms under carefully monitored and controlled conditions. Cell Expansions resemble in vivo conditions more closely than traditional 2D cell cultures by enabling cell–cell interactions and cell–matrix interactions in all directions. Cell Expansions find major applications in drug discovery and toxicity testing, regenerative medicine, stem cell research, and cancer research. The global Cell Expansion market exhibits lucrative opportunities due to the increasing adoption of Cell Expansion models in developing novel in vitro therapies and precision medicine.

The global Cell Expansion Market is estimated to be valued at US$ 16,035.5 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The widespread shift from 2D to Cell Expansion models among pharmaceutical companies and research organizations to gain more clinically relevant data from improved cell culture techniques is one of the major trends witnessed in the Cell Expansion market. Cell Expansions offer many advantages over 2D cell cultures including preservation of cell polarity, ability to form cell-cell junctions, and a extracellular matrix. Rising applications of 3D bioprinted constructs for drug testing and regenerative organ manufacturing is another key trend. Furthermore, automation and high-throughput screening capabilities of Cell Expansions will revolutionize drug discovery processes in the coming years.
Porter’s Analysis

Threat of new entrants: The cell expansion market requires significant capital investment and expertise to enter. Existing players enjoy economies of scale.

Bargaining power of buyers: Buyers have moderate bargaining power as there are many established players in the market providing similar cell expansion products and services.

Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to availability of substitute materials from different suppliers.

Threat of new substitutes: Threat of substitutes is low as cell expansion technology has advantages over other techniques for tissue engineering and regenerative medicine applications.

Competitive rivalry: The market is highly competitive with focus on new product launches, collaborations and geographical expansion.

Key Takeaways

The global cell expansion market is expected to witness high growth over the forecast period. The increasing research and development activities for cell-based therapies and tissue engineering are expected to drive the market.

Regional analysis: North America currently dominates the market and is expected to continue its dominance over the forecast period. This is attributed to growing biotechnology industry and increasing funding for cell-based research in the region. Asia Pacific is expected fastest growing market owing to rising healthcare expenditure, cheap manufacturing costs and increasing patient pool.

Key players: Key players operating in the cell expansion market are Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, Biologos, Cyagen US Inc. Focus on expansion strategies, collaborations and new product launches is observed among the key market players.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it